{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T15:00:25Z","timestamp":1786546825364,"version":"build-2736575974"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:00:00Z","timestamp":1776729600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:00:00Z","timestamp":1786492800000},"content-version":"vor","delay-in-days":113,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Psychiatry"],"DOI":"10.1038\/s41398-026-04048-9","type":"journal-article","created":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T15:05:22Z","timestamp":1776783922000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Establishment and validation of an Alzheimer\u2019s disease diagnostic model on the basis of exhaled volatile organic compound characteristics"],"prefix":"10.1038","volume":"16","author":[{"given":"Peng","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanwei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Che","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanxin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deli","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caixia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowei","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meixiu","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9675-5322","authenticated-orcid":false,"given":"Nan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,21]]},"reference":[{"key":"4048_CR1","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.3233\/JAD-210493","volume":"82","author":"F Li","year":"2021","unstructured":"Li F, Qin W, Zhu M, Jia J. Model-Based Projection of Dementia Prevalence in China and Worldwide: 2020-2050. J Alzheimers Dis. 2021;82:1823\u201331.","journal-title":"J Alzheimers Dis"},{"key":"4048_CR2","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1001\/jama.2019.4782","volume":"322","author":"Z Arvanitakis","year":"2019","unstructured":"Arvanitakis Z, Shah RC, Bennett DA. Diagnosis and Management of Dementia: Review. JAMA. 2019;322:1589\u201399.","journal-title":"JAMA"},{"key":"4048_CR3","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1111\/febs.16344","volume":"290","author":"F Yin","year":"2023","unstructured":"Yin F. Lipid metabolism and Alzheimer\u2019s disease: clinical evidence, mechanistic link and therapeutic promise. FEBS J. 2023;290:1420\u201353.","journal-title":"FEBS J"},{"key":"4048_CR4","doi-asserted-by":"crossref","unstructured":"Wang JT, Xu G, Ren RJ, Wang Y, Tang R, Huang Q, et al. The impacts of health insurance and resource on the burden of Alzheimer\u2019s disease and related dementias in the world population. Alzheimers Dement. 2023;19:967\u201379.","DOI":"10.1002\/alz.12730"},{"key":"4048_CR5","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","volume":"397","author":"P Scheltens","year":"2021","unstructured":"Scheltens P, De Strooper B, Kivipelto M, Holstege H, Ch\u00e9telat G, Teunissen CE, et al. Alzheimer\u2019s disease. Lancet. 2021;397:1577\u201390.","journal-title":"Lancet"},{"key":"4048_CR6","doi-asserted-by":"publisher","first-page":"13954","DOI":"10.3390\/ijms232213954","volume":"23","author":"E Passeri","year":"2022","unstructured":"Passeri E, Elkhoury K, Morsink M, Broersen K, Linder M, Tamayol A, et al. Alzheimer\u2019s disease: treatment strategies and their limitations. Int J Mol Sci. 2022;23:13954.","journal-title":"Int J Mol Sci"},{"key":"4048_CR7","doi-asserted-by":"crossref","unstructured":"Jack CR Jr, Andrews JS, Beach TG, Buracchio T, Dunn B, Graf A, et al. Revised criteria for diagnosis and staging of Alzheimer\u2019s disease: Alzheimer\u2019s association workgroup. Alzheimers Dement. 2024;20:5143\u201369.","DOI":"10.1002\/alz.13859"},{"key":"4048_CR8","doi-asserted-by":"publisher","first-page":"100623","DOI":"10.1016\/j.bj.2023.100623","volume":"46","author":"PC Moura","year":"2023","unstructured":"Moura PC, Raposo M, Vassilenko V. Breath volatile organic compounds (VOCs) as biomarkers for the diagnosis of pathological conditions: A review. Biomed J. 2023;46:100623.","journal-title":"Biomed J"},{"key":"4048_CR9","doi-asserted-by":"publisher","first-page":"e182815","DOI":"10.1001\/jamaoncol.2018.2815","volume":"5","author":"GB Hanna","year":"2019","unstructured":"Hanna GB, Boshier PR, Markar SR, Romano A. Accuracy and methodologic challenges of volatile organic compound-based exhaled breath tests for cancer diagnosis: a systematic review and meta-analysis. JAMA Oncol. 2019;5:e182815.","journal-title":"JAMA Oncol"},{"key":"4048_CR10","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1097\/JS9.0000000000000999","volume":"110","author":"M Zhou","year":"2024","unstructured":"Zhou M, Wang Q, Lu X, Zhang P, Yang R, Chen Y, et al. Exhaled breath and urinary volatile organic compounds (VOCs) for cancer diagnoses, and microbial-related VOC metabolic pathway analysis: a systematic review and meta-analysis. Int J Surg. 2024;110:1755\u201369.","journal-title":"Int J Surg"},{"key":"4048_CR11","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1136\/thoraxjnl-2020-215667","volume":"76","author":"W Ibrahim","year":"2021","unstructured":"Ibrahim W, Carr L, Cordell R, Wilde MJ, Salman D, Monks PS, et al. Breathomics for the clinician: the use of volatile organic compounds in respiratory diseases. Thorax. 2021;76:514\u201321.","journal-title":"Thorax"},{"key":"4048_CR12","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3390\/antiox12010129","volume":"12","author":"AS Oyerinde","year":"2023","unstructured":"Oyerinde AS, Selvaraju V, Babu JR, Geetha T. Potential role of oxidative stress in the production of volatile organic compounds in obesity. Antioxidants (Basel). 2023;12:129.","journal-title":"Antioxidants (Basel)"},{"key":"4048_CR13","doi-asserted-by":"publisher","first-page":"3488","DOI":"10.3390\/molecules28083488","volume":"28","author":"MP Bhandari","year":"2023","unstructured":"Bhandari MP, Polaka I, Vangravs R, Mezmale L, Veliks V, Kirshners A, et al. Volatile markers for cancer in exhaled breath-could they be the signature of the gut microbiota. Molecules. 2023;28:3488.","journal-title":"Molecules"},{"key":"4048_CR14","doi-asserted-by":"publisher","first-page":"1499104","DOI":"10.3389\/fmolb.2024.1499104","volume":"11","author":"T Furuhashi","year":"2024","unstructured":"Furuhashi T, Toda K, Weckwerth W. Review of cancer cell volatile organic compounds: their metabolism and evolution. Front Mol Biosci. 2024;11:1499104.","journal-title":"Front Mol Biosci"},{"key":"4048_CR15","doi-asserted-by":"publisher","first-page":"4852","DOI":"10.1002\/alz.13053","volume":"19","author":"B Jiao","year":"2023","unstructured":"Jiao B, Zhang S, Bei Y, Bu G, Yuan L, Zhu Y, et al. A detection model for cognitive dysfunction based on volatile organic compounds from a large Chinese community cohort. Alzheimers Dement. 2023;19:4852\u201362.","journal-title":"Alzheimers Dement"},{"key":"4048_CR16","doi-asserted-by":"publisher","first-page":"43","DOI":"10.2217\/nnm.12.105","volume":"8","author":"U Tisch","year":"2013","unstructured":"Tisch U, Schlesinger I, Ionescu R, Nassar M, Axelrod N, Robertman D, et al. Detection of Alzheimer\u2019s and Parkinson\u2019s disease from exhaled breath using nanomaterial-based sensors. Nanomedicine (Lond). 2013;8:43\u201356.","journal-title":"Nanomedicine (Lond)"},{"key":"4048_CR17","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.3390\/s17081783","volume":"17","author":"HC Lau","year":"2017","unstructured":"Lau HC, Yu JB, Lee HW, Huh JS, Lim JO. Investigation of exhaled breath samples from patients with Alzheimer\u2019s disease using gas chromatography-mass spectrometry and an exhaled breath sensor system. Sensors (Basel). 2017;17:1783.","journal-title":"Sensors (Basel)"},{"key":"4048_CR18","first-page":"e12088","volume":"12","author":"S Emam","year":"2020","unstructured":"Emam S, Nasrollahpour M, Colarusso B, Cai X, Grant S, Kulkarni P, et al. Detection of presymptomatic Alzheimer\u2019s disease through breath biomarkers. Alzheimers Dement (Amst). 2020;12:e12088.","journal-title":"Alzheimers Dement (Amst)"},{"key":"4048_CR19","doi-asserted-by":"publisher","first-page":"026003","DOI":"10.1088\/1752-7163\/ab6016","volume":"14","author":"A Tiele","year":"2020","unstructured":"Tiele A, Wicaksono A, Daulton E, Ifeachor E, Eyre V, Clarke S, et al. Breath-based non-invasive diagnosis of Alzheimer\u2019s disease: a pilot study. J Breath Res. 2020;14:026003.","journal-title":"J Breath Res"},{"key":"4048_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2021.101207","volume":"42","author":"A Liangou","year":"2021","unstructured":"Liangou A, Tasoglou A, Huber HJ, Wistrom C, Brody K, Menon PG, et al. A method for the identification of COVID-19 biomarkers in human breath using proton transfer reaction time-of-flight mass spectrometry. EClinicalMedicine. 2021;42:101207.","journal-title":"EClinicalMedicine"},{"key":"4048_CR21","doi-asserted-by":"publisher","first-page":"027108","DOI":"10.1088\/1752-7155\/6\/2\/027108","volume":"6","author":"AW Boots","year":"2012","unstructured":"Boots AW, van Berkel JJ, Dallinga JW, Smolinska A, Wouters EF, van Schooten FJ. The versatile use of exhaled volatile organic compounds in human health and disease. J Breath Res. 2012;6:027108.","journal-title":"J Breath Res"},{"key":"4048_CR22","doi-asserted-by":"publisher","first-page":"0002","DOI":"10.34133\/bmef.0002","volume":"4","author":"M Oxner","year":"2023","unstructured":"Oxner M, Trang A, Mehta J, Forsyth C, Swanson B, Keshavarzian A, et al. The Versatility and Diagnostic Potential of VOC Profiling for Noninfectious Diseases. BME Front. 2023;4:0002.","journal-title":"BME Front"},{"key":"4048_CR23","doi-asserted-by":"publisher","first-page":"c1168","DOI":"10.1136\/bmj.c1168","volume":"340","author":"A Frances","year":"2010","unstructured":"Frances A. The first draft of DSM-V. BMJ. 2010;340:c1168.","journal-title":"BMJ"},{"key":"4048_CR24","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/S1474-4422(14)70090-0","volume":"13","author":"B Dubois","year":"2014","unstructured":"Dubois B, Feldman HH, Jacova C, Hampel H, Molinuevo JL, Blennow K, et al. Advancing research diagnostic criteria for Alzheimer\u2019s disease: the IWG-2 criteria. Lancet Neurol. 2014;13:614\u201329.","journal-title":"Lancet Neurol"},{"key":"4048_CR25","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1097\/WAD.0000000000000034","volume":"28","author":"P Sachdev","year":"2014","unstructured":"Sachdev P, Kalaria R, O\u2019Brien J, Skoog I, Alladi S, Black SE, et al. Diagnostic criteria for vascular cognitive disorders: a VASCOG statement. Alzheimer Dis Assoc Disord. 2014;28:206\u201318.","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"4048_CR26","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","volume":"89","author":"IG McKeith","year":"2017","unstructured":"McKeith IG, Boeve BF, Dickson DW, Halliday G, Taylor JP, Weintraub D, et al. Diagnosis and management of dementia with lewy bodies: fourth consensus report of the DLB consortium. Neurology. 2017;89:88\u2013100.","journal-title":"Neurology"},{"key":"4048_CR27","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1093\/brain\/awr179","volume":"134","author":"K Rascovsky","year":"2011","unstructured":"Rascovsky K, Hodges JR, Knopman D, Mendez MF, Kramer JH, Neuhaus J, et al. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain. 2011;134:2456\u201377.","journal-title":"Brain"},{"key":"4048_CR28","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1212\/WNL.0b013e31821103e6","volume":"76","author":"ML Gorno-Tempini","year":"2011","unstructured":"Gorno-Tempini ML, Hillis AE, Weintraub S, Kertesz A, Mendez M, Cappa SF, et al. Classification of primary progressive aphasia and its variants. Neurology. 2011;76:1006\u201314.","journal-title":"Neurology"},{"key":"4048_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-37210-5","volume":"9","author":"A Smolinska","year":"2019","unstructured":"Smolinska A, Baranska A, Dallinga JW, Mensink RP, Baumgartner S, van de Heijning B, et al. Comparing patterns of volatile organic compounds exhaled in breath after consumption of two infant formulae with a different lipid structure: a randomized trial. Sci Rep. 2019;9:554.","journal-title":"Sci Rep"},{"key":"4048_CR30","doi-asserted-by":"publisher","first-page":"31835","DOI":"10.1039\/D3RA04522F","volume":"13","author":"H Wang","year":"2023","unstructured":"Wang H, Wei X, Wu Y, Zhang B, Chen Q, Fu W, et al. A combined screening study for evaluating the potential of exhaled acetone, isoprene, and nitric oxide as biomarkers of lung cancer. RSC Adv. 2023;13:31835\u201343.","journal-title":"RSC Adv"},{"key":"4048_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-59474-w","volume":"14","author":"H Wang","year":"2024","unstructured":"Wang H, Wu Y, Sun M, Cui X. Enhancing diagnosis of benign lesions and lung cancer through ensemble text and breath analysis: a retrospective cohort study. Sci Rep. 2024;14:8731.","journal-title":"Sci Rep"},{"key":"4048_CR32","doi-asserted-by":"publisher","first-page":"D622","DOI":"10.1093\/nar\/gkab1062","volume":"50","author":"DS Wishart","year":"2022","unstructured":"Wishart DS, Guo A, Oler E, Wang F, Anjum A, Peters H, et al. HMDB 5.0: the human metabolome database for 2022. Nucleic Acids Res. 2022;50:D622\u2013D631.","journal-title":"Nucleic Acids Res"},{"key":"4048_CR33","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa M. Goto S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 2000;28:27\u201330.","journal-title":"Nucleic Acids Res"},{"key":"4048_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2021.106003","volume":"175","author":"C Chen","year":"2022","unstructured":"Chen C, Lu J, Peng W, Mak MS, Yang Y, Zhu Z, et al. Acrolein, an endogenous aldehyde induces Alzheimer\u2019s disease-like pathologies in mice: A new sporadic AD animal model. Pharmacol Res. 2022;175:106003.","journal-title":"Pharmacol Res"},{"key":"4048_CR35","doi-asserted-by":"publisher","first-page":"1297984","DOI":"10.3389\/fnins.2023.1297984","volume":"17","author":"M Ramezani","year":"2023","unstructured":"Ramezani M, Fernando M, Eslick S, Asih PR, Shadfar S, Bandara E, et al. Ketone bodies mediate alterations in brain energy metabolism and biomarkers of Alzheimer\u2019s disease. Front Neurosci. 2023;17:1297984.","journal-title":"Front Neurosci"},{"key":"4048_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.796288","volume":"13","author":"Y Mou","year":"2022","unstructured":"Mou Y, Du Y, Zhou L, Yue J, Hu X, Liu Y, et al. Gut microbiota interact with the brain through systemic chronic inflammation: implications on neuroinflammation, neurodegeneration, and aging. Front Immunol. 2022;13:796288.","journal-title":"Front Immunol"},{"key":"4048_CR37","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/d41586-020-01152-8","volume":"581","author":"M Ishii","year":"2020","unstructured":"Ishii M, Iadecola C. Risk factor for Alzheimer\u2019s disease breaks the blood-brain barrier. Nature. 2020;581:31\u201332.","journal-title":"Nature"},{"key":"4048_CR38","doi-asserted-by":"publisher","DOI":"10.1111\/nan.12782","volume":"48","author":"C Kurz","year":"2022","unstructured":"Kurz C, Walker L, Rauchmann BS, Perneczky R. Dysfunction of the blood-brain barrier in Alzheimer\u2019s disease: evidence from human studies. Neuropathol Appl Neurobiol. 2022;48:e12782.","journal-title":"Neuropathol Appl Neurobiol"},{"key":"4048_CR39","doi-asserted-by":"publisher","first-page":"e14408","DOI":"10.15252\/emmm.202114408","volume":"14","author":"A Leuzy","year":"2022","unstructured":"Leuzy A, Mattsson-Carlgren N, Palmqvist S, Janelidze S, Dage JL, Hansson O. Blood-based biomarkers for Alzheimer\u2019s disease. EMBO Mol Med. 2022;14:e14408.","journal-title":"EMBO Mol Med"},{"key":"4048_CR40","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.3233\/JAD-131529","volume":"41","author":"M Yang","year":"2014","unstructured":"Yang M, Lu J, Miao J, Rizak J, Yang J, Zhai R, et al. Alzheimer\u2019s disease and methanol toxicity (part 1): chronic methanol feeding led to memory impairments and tau hyperphosphorylation in mice. J Alzheimers Dis. 2014;41:1117\u201329.","journal-title":"J Alzheimers Dis"},{"key":"4048_CR41","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.3233\/JAD-131532","volume":"41","author":"M Yang","year":"2014","unstructured":"Yang M, Miao J, Rizak J, Zhai R, Wang Z, Huma T, et al. Alzheimer\u2019s disease and methanol toxicity (part 2): lessons from four rhesus macaques (Macaca mulatta) chronically fed methanol. J Alzheimers Dis. 2014;41:1131\u201347.","journal-title":"J Alzheimers Dis"},{"key":"4048_CR42","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s13024-021-00483-y","volume":"16","author":"BC Farmer","year":"2021","unstructured":"Farmer BC, Williams HC, Devanney NA, Piron MA, Nation GK, Carter DJ, et al. APO\u03954 lowers energy expenditure in females and impairs glucose oxidation by increasing flux through aerobic glycolysis. Mol Neurodegener. 2021;16:62.","journal-title":"Mol Neurodegener"},{"key":"4048_CR43","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1007\/s40520-022-02120-0","volume":"34","author":"YL Xiong","year":"2022","unstructured":"Xiong YL, Therriault J, Ren SJ, Jing XJ, Zhang H, Alzheimer\u2019s Disease Neuroimaging Initiative, et al. The associations of serum valine with mild cognitive impairment and Alzheimer\u2019s disease. Aging Clin Exp Res. 2022;34:1807\u201317.","journal-title":"Aging Clin Exp Res"},{"key":"4048_CR44","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.scib.2023.11.040","volume":"69","author":"J Li","year":"2024","unstructured":"Li J. Indole-3-acetic acid, a potential therapeutic target in Alzheimer\u2019s disease. Sci Bull (Beijing). 2024;69:146\u20137.","journal-title":"Sci Bull (Beijing)"},{"key":"4048_CR45","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s13195-023-01379-3","volume":"16","author":"YX Qiang","year":"2024","unstructured":"Qiang YX, You J, He XY, Guo Y, Deng YT, Gao PY, et al. Plasma metabolic profiles predict future dementia and dementia subtypes: a prospective analysis of 274,160 participants. Alzheimers Res Ther. 2024;16:16.","journal-title":"Alzheimers Res Ther"},{"key":"4048_CR46","doi-asserted-by":"publisher","first-page":"8294","DOI":"10.1002\/alz.14249","volume":"20","author":"R Batra","year":"2024","unstructured":"Batra R, Krumsiek J, Wang X, Allen M, Blach C, Kastenm\u00fcller G, et al. Comparative brain metabolomics reveals shared and distinct metabolic alterations in Alzheimer\u2019s disease and progressive supranuclear palsy. Alzheimers Dement. 2024;20:8294\u2013307.","journal-title":"Alzheimers Dement"},{"key":"4048_CR47","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1186\/s13195-023-01359-7","volume":"15","author":"XY Chua","year":"2023","unstructured":"Chua XY, Torta F, Chong JR, Venketasubramanian N, Hilal S, Wenk MR, et al. Lipidomics profiling reveals distinct patterns of plasma sphingolipid alterations in Alzheimer\u2019s disease and vascular dementia. Alzheimers Res Ther. 2023;15:214.","journal-title":"Alzheimers Res Ther"},{"key":"4048_CR48","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s13024-020-00378-4","volume":"15","author":"HR Bulgart","year":"2020","unstructured":"Bulgart HR, Neczypor EW, Wold LE, Mackos AR. Microbial involvement in Alzheimer disease development and progression. Mol Neurodegener. 2020;15:42.","journal-title":"Mol Neurodegener"},{"key":"4048_CR49","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1136\/gutjnl-2021-326269","volume":"71","author":"C Chen","year":"2022","unstructured":"Chen C, Liao J, Xia Y, Liu X, Jones R, Haran J, et al. Gut microbiota regulate Alzheimer\u2019s disease pathologies and cognitive disorders via PUFA-associated neuroinflammation. Gut. 2022;71:2233\u201352.","journal-title":"Gut"},{"key":"4048_CR50","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1007\/s12275-018-8297-7","volume":"56","author":"T Nguyen","year":"2018","unstructured":"Nguyen T, Fujimura Y, Mimura I, Fujii Y, Nguyen NL, Arakawa K, et al. Cultivable butyrate-producing bacteria of elderly Japanese diagnosed with Alzheimer\u2019s disease. J Microbiol. 2018;56:760\u201371.","journal-title":"J Microbiol"},{"key":"4048_CR51","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s00213-021-06025-0","volume":"239","author":"C Wang","year":"2022","unstructured":"Wang C, Zheng D, Weng F, Jin Y, He L. Sodium butyrate ameliorates the cognitive impairment of Alzheimer\u2019s disease by regulating the metabolism of astrocytes. Psychopharmacology (Berl). 2022;239:215\u201327.","journal-title":"Psychopharmacology (Berl)"},{"key":"4048_CR52","doi-asserted-by":"publisher","DOI":"10.1002\/mnfr.201900636","volume":"64","author":"J Sun","year":"2020","unstructured":"Sun J, Xu J, Yang B, Chen K, Kong Y, Fang N, et al. Effect of clostridium butyricum against microglia-mediated neuroinflammation in Alzheimer\u2019s disease via regulating gut microbiota and metabolites butyrate. Mol Nutr Food Res. 2020;64:e1900636.","journal-title":"Mol Nutr Food Res"},{"key":"4048_CR53","doi-asserted-by":"publisher","first-page":"949","DOI":"10.3390\/metabo12100949","volume":"12","author":"M Fran\u00e7ois","year":"2022","unstructured":"Fran\u00e7ois M, Karpe AV, Liu JW, Beale DJ, Hor M, Hecker J, et al. Multi-omics, an integrated approach to identify novel blood biomarkers of Alzheimer\u2019s disease. Metabolites. 2022;12:949.","journal-title":"Metabolites"},{"key":"4048_CR54","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1016\/j.cmet.2022.07.014","volume":"34","author":"L Traxler","year":"2022","unstructured":"Traxler L, Herdy JR, Stefanoni D, Eichhorner S, Pelucchi S, Sz\u00fccs A, et al. Warburg-like metabolic transformation underlies neuronal degeneration in sporadic Alzheimer\u2019s disease. Cell Metab. 2022;34:1248\u2013.e6.","journal-title":"Cell Metab"},{"key":"4048_CR55","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s13195-023-01269-8","volume":"15","author":"S Paciotti","year":"2023","unstructured":"Paciotti S, Wojda\u0142a AL, Bellomo G, Toja A, Chipi E, Piersma SR, et al. Potential diagnostic value of CSF metabolism-related proteins across the Alzheimer\u2019s disease continuum. Alzheimers Res Ther. 2023;15:124.","journal-title":"Alzheimers Res Ther"},{"key":"4048_CR56","doi-asserted-by":"publisher","first-page":"S453","DOI":"10.3233\/JAD-220514","volume":"94","author":"N Chhimpa","year":"2023","unstructured":"Chhimpa N, Singh N, Puri N, Kayath HP. The novel role of mitochondrial citrate synthase and citrate in the pathophysiology of Alzheimer\u2019s disease. J Alzheimers Dis. 2023;94:S453\u2013S472.","journal-title":"J Alzheimers Dis"},{"key":"4048_CR57","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1186\/s13195-024-01552-2","volume":"16","author":"K Sakimura","year":"2024","unstructured":"Sakimura K, Kawai T, Nashida R, Ishida Y, Harada K, Suzuki T, et al. A novel PDHK inhibitor restored cognitive dysfunction and limited neurodegeneration without affecting amyloid pathology in 5xFAD mouse, a model of Alzheimer\u2019s disease. Alzheimers Res Ther. 2024;16:197.","journal-title":"Alzheimers Res Ther"},{"key":"4048_CR58","doi-asserted-by":"publisher","first-page":"3785","DOI":"10.3390\/ijms23073785","volume":"23","author":"CG Ardanaz","year":"2022","unstructured":"Ardanaz CG, Ram\u00edrez MJ, Solas M. Brain metabolic alterations in Alzheimer\u2019s disease. Int J Mol Sci. 2022;23:3785.","journal-title":"Int J Mol Sci"},{"key":"4048_CR59","doi-asserted-by":"publisher","first-page":"4351","DOI":"10.3390\/ijms23084351","volume":"23","author":"Q Wang","year":"2022","unstructured":"Wang Q, Duan L, Li X, Wang Y, Guo W, Guan F, et al. Glucose metabolism, neural cell senescence and Alzheimer\u2019s disease. Int J Mol Sci. 2022;23:4351.","journal-title":"Int J Mol Sci"},{"key":"4048_CR60","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2024.1483708","volume":"18","author":"SM Crivelli","year":"2024","unstructured":"Crivelli SM, Gaifullina A, Chatton JY. Exploring the role of mitochondrial uncoupling protein 4 in brain metabolism: implications for Alzheimer\u2019s disease. Front Neurosci. 2024;18:1483708.","journal-title":"Front Neurosci"}],"container-title":["Translational Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41398-026-04048-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-026-04048-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-026-04048-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T14:03:16Z","timestamp":1786543396000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41398-026-04048-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,21]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4048"],"URL":"https:\/\/doi.org\/10.1038\/s41398-026-04048-9","relation":{},"ISSN":["2158-3188"],"issn-type":[{"value":"2158-3188","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,21]]},"assertion":[{"value":"21 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study followed the Declaration of Helsinki and was approved by the Ethics Committee of Tianjin Medical University General Hospital. Written informed consent was obtained from all participants.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"411"}}